SKI Market

A+| A| A-|

Indian Indices

Sensex

73,134.32 1,186.77
( 1.65%)

Global Indices

Nasdaq

46,363.90 1,126.75
(2.49%)

Dow Jones

6,550.24 185.52
(2.91%)

Hang Seng

53,589.67 2,525.95
(4.95%)

Nikkei 225

10,364.79 188.34
(1.85%)

Forex

USD-INR

94.31 -0.22
(-0.23%)

EUR-INR

108.30 -0.48
(-0.44%)

GBP-INR

124.69 -0.63
(-0.50%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

37.46

739.92

EPS(TTM)

Face Value()

Div & Yield %

16.76

0.24

Back

NCL Research and Financial Services Ltd - Board Meeting Intimation for Approval Of Unaudited Financial Results For QE Sept 30 2025

Oct 13,2025

NCL Research & Financial Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 inter alia to consider and approve Unaudited Financial Results for QE Sept 30 2025

73,134.32 1,186.77 ( 1.65%)

46,363.90 1,126.75 (2.49%)

6,550.24 185.52 (2.91%)

53,589.67 2,525.95 (4.95%)

10,364.79 188.34 (1.85%)

94.31 -0.22 (-0.23%)

108.30 -0.48 (-0.44%)

124.69 -0.63 (-0.50%)

0.59 0.00 (0.19%)